The Pennant Group, Inc. (PNTG) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for The Pennant Group, Inc. (PNTG:NASDAQ), powered by AI.

Current Price
$29.66
P/E Ratio
41.0
Market Cap
925M
Sector
Healthcare
What is the The Pennant Group, Inc. stock price forecast?

The Pennant Group, Inc. is currently trading at $29.66. View real-time AI analysis on Alpha Lenz.

What is The Pennant Group, Inc. insider trading activity?

View the latest insider trading data for The Pennant Group, Inc. on Alpha Lenz.

What is The Pennant Group, Inc.'s P/E ratio?

The Pennant Group, Inc.'s P/E ratio is 41.0.

The Pennant Group, Inc.

$29.66
NASDAQPNTG
Ask about The Pennant Group, Inc.'s future dividend policy...
Alpha Chat Insight

The Pennant Group, Inc. trades at a P/E of 41.0 (premium valuation) with solid ROE of 10.4%. 3Y revenue CAGR of 16.5% highlights clear growth momentum.

Ask for details

Company Overview

Pennant Group, Inc. is a publicly traded healthcare company engaged in providing a range of post-acute healthcare services throughout the United States. Its primary function is to operate home health and hospice agencies, as well as senior living communities, dedicated to offering skilled nursing and housing services to elderly populations. The company particularly serves the needs of individuals requiring specialized care following hospitalizations or those managing chronic health conditions, thereby playing a significant role in the continuum of care for aging demographics. Notably, Pennant Group, Inc. impacts the healthcare and real estate sectors, given its combined focus on healthcare services and residential community management. It stands out for its decentralized service model designed to empower local leadership and maximize community engagement, thereby tailoring services to the specific needs of each location. In the financial market, Pennant Group, Inc. represents a blend of healthcare provision with an emphasis on home-based care solutions, reflecting broader industry trends towards personalized and localized healthcare delivery systems. As the demand for senior care services continues to rise amidst an aging population, the company holds an important place in addressing these evolving healthcare needs.

CEOMr. Brent J. Guerisoli
SectorHealthcare
IndustryMedical Care Facilities
Employees7,000

Company Statistics

(FY 2024)

Profile

Market Cap$925.13M
Revenue$695.24M
Shares Out0.00
Employees7,000

Margins

Gross13.49%
EBITDA6.29%
Operating5.38%
Pre-Tax4.51%
Net3.50%

Valuation

P/E41.01
P/B3.15
EV/Sales1.33
EV/EBITDA27.25
P/FCF30.53

Growth (CAGR)

Rev 3Yr16.50%
Rev 5Yr15.48%
Op Inc 3Yr70.50%
Op Inc 5Yr45.86%
Net Inc 3Yr124.61%
Net Inc 5Yr50.28%

Returns

ROA3.99%
ROE10.40%
ROIC6.29%

Financial Health

Cash & Cash Equivalents$24.25M
Net Debt$343.31M
Debt/Equity117.82%
Interest CovN/A
Ask Alpha Chat

Frequently Asked Questions

Alpha Lenz
Singapore
CEO: Kyungtae Kim | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2025 Treasurer. All rights reserved.
The Pennant Group, Inc. (Healthcare) Stock Forecast & Analysis $29.66 | Alpha Lenz